Rob Isbitz says the best ETFs are diversified, but not hyper-diversified.
1. The Cannabis Investing Podcast episode 'Cannabis ETF deep dive' focuses on cannabis ETFs and how Rob Isbitz evaluates them.
2. Host Reena Sherbel interviews Rob Isbitz, a Seeking Alpha ETF analyst who also writes for Sun Garden Investment Publishing and runs etfyourself.com.
3. The episode asks what investors actually own inside cannabis ETFs and how to judge them beyond simple performance tables.
4. Isbitz says he spent 27 years as a financial advisor before moving into research and ETF analysis.
5. He names seven cannabis ETFs and says he grouped them into A tier and B tier after reviewing their structures.
6. He puts MSOS, MJ, and POTX in his top tier and says YOLO, CNBS, CX, and Tote sit in the lower tier.
7. He notes that MSOS is over $400 million in assets, MJ is about $188 million, and POTX is about $27 million.
8. He says MJ has a quirk because 50% of the fund is in MJUS, which reduces its attractiveness to him.
9. He favors smaller baskets, such as a 15-stock ETF, because he can track every holding on a watch list.
10. He says some of the best ETFs are diversified without being 'hyper-diversified.'
11. He emphasizes that ETF analysis requires more than a few headline statistics.
12. He says MSOS uses swaps for much of its exposure, which raises counterparty risk that a surface-level report can miss.
13. He argues that liquidity depends on the underlying holdings, not just the ETF's trading volume.
14. He gives the example of a Dow Jones 30 ETF with $10 million in assets as potentially liquid if the holdings are liquid.
15. He says expense ratio matters less in volatile niches like cannabis, microcaps, cybersecurity, and cloud computing.
16. He says the active cannabis ETFs use the S&P 500 as their benchmark, which he finds unusual for this sector.
17. On technicals, he says he looks across monthly, quarterly, one-minute, and five-minute charts.
18. He says cannabis ETFs currently need to 'show me' a sustainable breakout before he would raise exposure.
19. The conversation stays analytical and tactical, with Sherbel pushing for clear portfolio guidance and Isbitz answering in a structured, educational style.
20. Investors comparing cannabis ETFs, tactical traders, and portfolio builders would get the most value, while investors seeking company fundamentals alone may skip it.
